Taiho Ventures

Biotechnology · Venture Capital
$478.5Mraised by its portfolio in 12 months
12open roles in its portfolio
25investments
6exits

Overview

Taiho Ventures is the corporate venture capital arm of Taiho Pharmaceutical, investing in biotechnology startups aligned with its growth strategy. It backs global companies developing novel therapeutics and enabling technologies, with a particular interest in oncology and other areas of strategic importance to its parent. The firm was established in 2016 in California as a subsidiary of Taiho Pharmaceutical, a Tokyo-based drug maker that belongs to the Otsuka group.

Key facts

These are the key facts about Taiho Ventures on Alion as of Nov 13, 2026. Taiho Ventures is headquartered in Palo Alto, United States. It was founded in 2016.

Headquarters
Palo Alto, United StatesAlion company profile, updated Sep 17, 2026
Founded
2016Alion company profile, updated Sep 17, 2026
Employees
10+Alion company profile, an estimated range

Investor profile

Venture capital
Investments
25
12 of them startups
Hiring now
3
12 open roles
Rounds in 12 months
5
$478.5M raised
Exits
6
Focusshare of its companies
Health Care 75%Biotechnology 42%Artificial Intelligence 17%
Where its companies are
United States 28%Germany 8%United Kingdom 4%
Stage of its companies
Series B 43%Series A 29%Pre-seed & seed 14%Series C and later 14%

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Palo Alto United States
HQ
10-50 est. staff

How to cite this page

Alion, "Taiho Ventures: key facts", as of Nov 13, 2026. https://alion.io/company/taiho-ventures

These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0